BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Świątkiewicz I, Magielski P, Kubica J. C-Reactive Protein as a Risk Marker for Post-Infarct Heart Failure over a Multi-Year Period. Int J Mol Sci 2021;22:3169. [PMID: 33804661 DOI: 10.3390/ijms22063169] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Perricone C, Cafaro G, Fiumicelli E, Bursi R, Bogdanos D, Riccucci I, Gerli R, Bartoloni E. Predictors of complete 24-month remission and flare in patients with polymyalgia rheumatica. Clin Exp Med 2022. [PMID: 36566303 DOI: 10.1007/s10238-022-00976-0] [Reference Citation Analysis]
2 Liu S, Jiang H, Dhuromsingh M, Dai L, Jiang Y, Zeng H. Evaluation of C-reactive protein as predictor of adverse prognosis in acute myocardial infarction after percutaneous coronary intervention: A systematic review and meta-analysis from 18,715 individuals. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1013501] [Reference Citation Analysis]
3 Stătescu C, Anghel L, Tudurachi B, Leonte A, Benchea L, Sascău R. From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction. IJMS 2022;23:9168. [DOI: 10.3390/ijms23169168] [Reference Citation Analysis]
4 Haryono A, Ramadhiani R, Ryanto GRT, Emoto N. Endothelin and the Cardiovascular System: The Long Journey and Where We Are Going. Biology (Basel) 2022;11:759. [PMID: 35625487 DOI: 10.3390/biology11050759] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Walkowski B, Kleibert M, Majka M, Wojciechowska M. Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart. Cells 2022;11:1553. [DOI: 10.3390/cells11091553] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Koziolova NA, Goryacheva OG, Litsinger IF. Contribution of inflammation to heart failure development in human immunodeficiency virus-infected patients. Russ J Cardiol 2022;27:4862. [DOI: 10.15829/1560-4071-2022-4862] [Reference Citation Analysis]
7 Shen S, Wang Z, Sun H, Ma L. Role of NLRP3 Inflammasome in Myocardial Ischemia-Reperfusion Injury and Ventricular Remodeling. Med Sci Monit 2022;28:e934255. [PMID: 35042840 DOI: 10.12659/MSM.934255] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Holzknecht M, Tiller C, Reindl M, Lechner I, Fink P, Lunger P, Mayr A, Henninger B, Brenner C, Klug G, Bauer A, Metzler B, Reinstadler SJ. Association of C-Reactive Protein Velocity with Early Left Ventricular Dysfunction in Patients with First ST-Elevation Myocardial Infarction. J Clin Med 2021;10:5494. [PMID: 34884196 DOI: 10.3390/jcm10235494] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
9 Świątkiewicz I, Di Somma S, De Fazio L, Mazzilli V, Taub PR. Effectiveness of Intensive Cardiac Rehabilitation in High-Risk Patients with Cardiovascular Disease in Real-World Practice. Nutrients 2021;13:3883. [PMID: 34836144 DOI: 10.3390/nu13113883] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
10 Vaidya K, Tucker B, Patel S, Ng MKC. Acute Coronary Syndromes (ACS)-Unravelling Biology to Identify New Therapies-The Microcirculation as a Frontier for New Therapies in ACS. Cells 2021;10:2188. [PMID: 34571836 DOI: 10.3390/cells10092188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Tucker B, Vaidya K, Cochran BJ, Patel S. Inflammation during Percutaneous Coronary Intervention-Prognostic Value, Mechanisms and Therapeutic Targets. Cells 2021;10:1391. [PMID: 34199975 DOI: 10.3390/cells10061391] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]